Lipfendra is the first oral PCSK9 inhibitor and was just approved by FDA. PCSK9 inhibitors are one of the most effective cholesterol-lowering medications we have. They work by helping your liver remove more LDL (“bad”) cholesterol from your bloodstream, often lowering LDL up to 60%. We typically use them for people who: 1. Have already had a heart attack or stroke and still have elevated LDL despite statins and zetia 2. Have familial hypercholesterolemia 3. Can’t tolerate statins and need additional LDL lowering Cardiovascular outcome data for Lipfendra should be available in a few years. #HeartHealth #Cholesterol #Lipfendra